Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable Non-Small Cell Lung Cancer × Nivolumab × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 212 Lung Neoplasms 66 Melanoma 49 Carcinoma, Renal Cell 39 Small Cell Lung Carcinoma 29 Colorectal Neoplasms 23 Squamous Cell Carcinoma of Head and Neck 22 Neoplasms 22 Carcinoma, Transitional Cell 22 Triple Negative Breast Neoplasms 20 Neoplasm Metastasis 19 Carcinoma, Hepatocellular 16 Mesothelioma 15 Ovarian Neoplasms 14 Mesothelioma, Malignant 14 Pancreatic Neoplasms 13 Stomach Neoplasms 12 Breast Neoplasms 12 Uterine Cervical Neoplasms 10 Head and Neck Neoplasms 10 Urinary Bladder Neoplasms 9 Carcinoma, Merkel Cell 9 Kidney Neoplasms 8 Adenocarcinoma of Lung 7 Esophageal Neoplasms 6 Endometrial Neoplasms 6 Carcinoma, Squamous Cell 6 Brain Neoplasms 6 Lymphoma 5 Gastrointestinal Neoplasms 5

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡